The New York Entrepreneur

Moderna’s experimental mpox vaccine reduces severity of disease, early study finds  

Read Time:8 Second

Amid mounting concerns about the spread of mpox, an experimental vaccine from Moderna may be poised to offer additional protection beyond currently available vaccines, research published Wednesday shows. 

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post NFL’s next big media rights payday is years off — and subject to a shifting industry
Next post Factory orders rise in July after two months of weakness